Reduction of Transthyretin Expression by AAV Gene Delivery of a Novel Endonuclease in Mice

被引：0
|
作者：
Greig, Jenny A. [1 ]
Ashley, Scott N. [1 ]
Gorsuch, Cassandra [2 ]
Chorazeczewski, Joanna [1 ]
Furmanak, Thomas [1 ]
Zhu, Yanqing [1 ]
Bell, Peter [1 ]
Sharer, Wendy [2 ]
Li, Hui [2 ]
Smith, Jeff [2 ]
Clark, Peter [1 ]
Breton, Camilo [1 ]
Wilson, James M. [1 ]
机构：
[1] Univ Penn, Dept Med, Gene Therapy Program, Philadelphia, PA 19104 USA
[2] Precis BioSci, Durham, NC USA
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
996
引用
收藏
页码：463 / 463
页数：1
相关论文
共 50 条
  • [21] Functional expression of complement factor I following AAV-mediated gene delivery in the retina of mice and human cells
    Anna K. Dreismann
    Michelle E. McClements
    Alun R. Barnard
    Elise Orhan
    Jane P. Hughes
    Peter J. Lachmann
    Robert E. MacLaren
    Gene Therapy, 2021, 28 : 265 - 276
  • [22] Rationally Designed a Novel AAV Capsid for Intra-Articular Gene Delivery
    Luo, Shuang
    Xie, Qing
    Li, Qingwei
    Zheng, Qiang
    MOLECULAR THERAPY, 2024, 32 (04) : 263 - 263
  • [23] Engineering and Evaluation of Novel AAV Serotypes for Gene Delivery to the Central Nervous System
    Ojala, David S.
    McGovern, Kyle
    Lee, Clancy
    Andrews, Lori
    Nguyen, Hoang-Oanh B.
    Shen, Weiran
    Goodwin, Alicia
    Ledeboer, Annemarie
    Van, Ken C.
    Gasper, Carolyn
    Surosky, Richard
    Zeitler, Bryan J.
    Riley, Brigit E.
    Pooler, Amy M.
    MOLECULAR THERAPY, 2020, 28 (04) : 12 - 12
  • [24] Rationally engineered novel AAV capsids for intra-articular gene delivery
    Li, Wenjun
    Feng, Susi Liu
    Herrschaft, Lizette
    Samulski, R. Jude
    Li, Chengwen
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (01)
  • [25] TISSUE-SPECIFIC AND DEVELOPMENTAL EXPRESSION OF HUMAN TRANSTHYRETIN GENE IN TRANSGENIC MICE
    YAMAMURA, K
    WAKASUGI, S
    MAEDA, S
    INOMOTO, T
    IWANAGA, T
    UEHIRA, M
    ARAKI, K
    MIYAZAKI, J
    SHIMADA, K
    DEVELOPMENTAL GENETICS, 1987, 8 (04): : 195 - 205
  • [26] Engineered CHO cells as a novel AAV production platform for gene therapy delivery
    Abdou Nagy
    Lina Chakrabarti
    James Kurasawa
    Sri Hari Raju Mulagapati
    Paul Devine
    Jamy Therres
    Zhongying Chen
    Albert E. Schmelzer
    Scientific Reports, 13
  • [27] Engineered CHO cells as a novel AAV production platform for gene therapy delivery
    Nagy, Abdou
    Chakrabarti, Lina
    Kurasawa, James
    Mulagapati, Sri Hari Raju
    Devine, Paul
    Therres, Jamy
    Chen, Zhongying
    Schmelzer, Albert E.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [28] Sustained expression and safety of human GNE in normal mice after gene transfer based on AAV8 systemic delivery
    Mitrani-Rosenbaum, Stella
    Yakovlev, Lena
    Cohen, Michal Becker
    Telem, Michal
    Elbaz, Moran
    Yanay, Nurit
    Yotvat, Hagit
    Ben Shlomo, Uri
    Harazi, Avi
    Fellig, Yakov
    Argov, Zohar
    Sela, Ilan
    NEUROMUSCULAR DISORDERS, 2012, 22 (11) : 1015 - 1024
  • [29] Self-complementary AAV mediates gene targeting and enhances endonuclease delivery for double-strand break repair
    Hirsch, M. L.
    Green, L.
    Porteus, M. H.
    Samulski, R. J.
    GENE THERAPY, 2010, 17 (09) : 1175 - 1180
  • [30] Self-complementary AAV mediates gene targeting and enhances endonuclease delivery for double-strand break repair
    M L Hirsch
    L Green
    M H Porteus
    R J Samulski
    Gene Therapy, 2010, 17 : 1175 - 1180
12345